Global Pharmacogenomics (PGx) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Pharmacogenomics (PGx) market size was valued at US$ 7589.1 million in 2023. With growing demand in downstream market, the Pharmacogenomics (PGx) is forecast to a readjusted size of US$ 14440 million by 2030 with a CAGR of 9.6% during review period.
The research report highlights the growth potential of the global Pharmacogenomics (PGx) market. Pharmacogenomics (PGx) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmacogenomics (PGx). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmacogenomics (PGx) market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pharmacogenomics (PGx) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmacogenomics (PGx) market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction (PCR), Microarray), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmacogenomics (PGx) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmacogenomics (PGx) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmacogenomics (PGx) industry. This include advancements in Pharmacogenomics (PGx) technology, Pharmacogenomics (PGx) new entrants, Pharmacogenomics (PGx) new investment, and other innovations that are shaping the future of Pharmacogenomics (PGx).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmacogenomics (PGx) market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmacogenomics (PGx) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmacogenomics (PGx) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmacogenomics (PGx) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmacogenomics (PGx) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmacogenomics (PGx) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmacogenomics (PGx) market.
Market Segmentation:
Pharmacogenomics (PGx) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Pharmacogenomics (PGx) market size was valued at US$ 7589.1 million in 2023. With growing demand in downstream market, the Pharmacogenomics (PGx) is forecast to a readjusted size of US$ 14440 million by 2030 with a CAGR of 9.6% during review period.
The research report highlights the growth potential of the global Pharmacogenomics (PGx) market. Pharmacogenomics (PGx) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmacogenomics (PGx). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmacogenomics (PGx) market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pharmacogenomics (PGx) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmacogenomics (PGx) market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction (PCR), Microarray), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmacogenomics (PGx) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmacogenomics (PGx) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmacogenomics (PGx) industry. This include advancements in Pharmacogenomics (PGx) technology, Pharmacogenomics (PGx) new entrants, Pharmacogenomics (PGx) new investment, and other innovations that are shaping the future of Pharmacogenomics (PGx).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmacogenomics (PGx) market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmacogenomics (PGx) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmacogenomics (PGx) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmacogenomics (PGx) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmacogenomics (PGx) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmacogenomics (PGx) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmacogenomics (PGx) market.
Market Segmentation:
Pharmacogenomics (PGx) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Polymerase Chain Reaction (PCR)
- Microarray
- Sequencing
- Other
- Cardiovascular Diseases (CVD)
- Central Nervous System (CNS)
- Cancer/Oncology
- Infectious Diseases
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Affymetrix, Inc.
- Assurex Health, Inc
- Astrazeneca
- GeneDX
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- Pathway Genomics
- Pfizer, Inc
- Qiagen, Inc.
- Rocheg
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
- Transgenomic, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmacogenomics (PGx) Market Size 2019-2030
2.1.2 Pharmacogenomics (PGx) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmacogenomics (PGx) Segment by Type
2.2.1 Polymerase Chain Reaction (PCR)
2.2.2 Microarray
2.2.3 Sequencing
2.2.4 Other
2.3 Pharmacogenomics (PGx) Market Size by Type
2.3.1 Pharmacogenomics (PGx) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
2.4 Pharmacogenomics (PGx) Segment by Application
2.4.1 Cardiovascular Diseases (CVD)
2.4.2 Central Nervous System (CNS)
2.4.3 Cancer/Oncology
2.4.4 Infectious Diseases
2.4.5 Other
2.5 Pharmacogenomics (PGx) Market Size by Application
2.5.1 Pharmacogenomics (PGx) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
3 PHARMACOGENOMICS (PGX) MARKET SIZE BY PLAYER
3.1 Pharmacogenomics (PGx) Market Size Market Share by Players
3.1.1 Global Pharmacogenomics (PGx) Revenue by Players (2019-2024)
3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacogenomics (PGx) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACOGENOMICS (PGX) BY REGIONS
4.1 Pharmacogenomics (PGx) Market Size by Regions (2019-2024)
4.2 Americas Pharmacogenomics (PGx) Market Size Growth (2019-2024)
4.3 APAC Pharmacogenomics (PGx) Market Size Growth (2019-2024)
4.4 Europe Pharmacogenomics (PGx) Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmacogenomics (PGx) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmacogenomics (PGx) Market Size by Country (2019-2024)
5.2 Americas Pharmacogenomics (PGx) Market Size by Type (2019-2024)
5.3 Americas Pharmacogenomics (PGx) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacogenomics (PGx) Market Size by Region (2019-2024)
6.2 APAC Pharmacogenomics (PGx) Market Size by Type (2019-2024)
6.3 APAC Pharmacogenomics (PGx) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmacogenomics (PGx) by Country (2019-2024)
7.2 Europe Pharmacogenomics (PGx) Market Size by Type (2019-2024)
7.3 Europe Pharmacogenomics (PGx) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmacogenomics (PGx) by Region (2019-2024)
8.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACOGENOMICS (PGX) MARKET FORECAST
10.1 Global Pharmacogenomics (PGx) Forecast by Regions (2025-2030)
10.1.1 Global Pharmacogenomics (PGx) Forecast by Regions (2025-2030)
10.1.2 Americas Pharmacogenomics (PGx) Forecast
10.1.3 APAC Pharmacogenomics (PGx) Forecast
10.1.4 Europe Pharmacogenomics (PGx) Forecast
10.1.5 Middle East & Africa Pharmacogenomics (PGx) Forecast
10.2 Americas Pharmacogenomics (PGx) Forecast by Country (2025-2030)
10.2.1 United States Pharmacogenomics (PGx) Market Forecast
10.2.2 Canada Pharmacogenomics (PGx) Market Forecast
10.2.3 Mexico Pharmacogenomics (PGx) Market Forecast
10.2.4 Brazil Pharmacogenomics (PGx) Market Forecast
10.3 APAC Pharmacogenomics (PGx) Forecast by Region (2025-2030)
10.3.1 China Pharmacogenomics (PGx) Market Forecast
10.3.2 Japan Pharmacogenomics (PGx) Market Forecast
10.3.3 Korea Pharmacogenomics (PGx) Market Forecast
10.3.4 Southeast Asia Pharmacogenomics (PGx) Market Forecast
10.3.5 India Pharmacogenomics (PGx) Market Forecast
10.3.6 Australia Pharmacogenomics (PGx) Market Forecast
10.4 Europe Pharmacogenomics (PGx) Forecast by Country (2025-2030)
10.4.1 Germany Pharmacogenomics (PGx) Market Forecast
10.4.2 France Pharmacogenomics (PGx) Market Forecast
10.4.3 UK Pharmacogenomics (PGx) Market Forecast
10.4.4 Italy Pharmacogenomics (PGx) Market Forecast
10.4.5 Russia Pharmacogenomics (PGx) Market Forecast
10.5 Middle East & Africa Pharmacogenomics (PGx) Forecast by Region (2025-2030)
10.5.1 Egypt Pharmacogenomics (PGx) Market Forecast
10.5.2 South Africa Pharmacogenomics (PGx) Market Forecast
10.5.3 Israel Pharmacogenomics (PGx) Market Forecast
10.5.4 Turkey Pharmacogenomics (PGx) Market Forecast
10.5.5 GCC Countries Pharmacogenomics (PGx) Market Forecast
10.6 Global Pharmacogenomics (PGx) Forecast by Type (2025-2030)
10.7 Global Pharmacogenomics (PGx) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Pharmacogenomics (PGx) Product Offered
11.1.3 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Affymetrix, Inc.
11.2.1 Affymetrix, Inc. Company Information
11.2.2 Affymetrix, Inc. Pharmacogenomics (PGx) Product Offered
11.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Affymetrix, Inc. Main Business Overview
11.2.5 Affymetrix, Inc. Latest Developments
11.3 Assurex Health, Inc
11.3.1 Assurex Health, Inc Company Information
11.3.2 Assurex Health, Inc Pharmacogenomics (PGx) Product Offered
11.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Assurex Health, Inc Main Business Overview
11.3.5 Assurex Health, Inc Latest Developments
11.4 Astrazeneca
11.4.1 Astrazeneca Company Information
11.4.2 Astrazeneca Pharmacogenomics (PGx) Product Offered
11.4.3 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Astrazeneca Main Business Overview
11.4.5 Astrazeneca Latest Developments
11.5 GeneDX
11.5.1 GeneDX Company Information
11.5.2 GeneDX Pharmacogenomics (PGx) Product Offered
11.5.3 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GeneDX Main Business Overview
11.5.5 GeneDX Latest Developments
11.6 Illumina, Inc.
11.6.1 Illumina, Inc. Company Information
11.6.2 Illumina, Inc. Pharmacogenomics (PGx) Product Offered
11.6.3 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Illumina, Inc. Main Business Overview
11.6.5 Illumina, Inc. Latest Developments
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Information
11.7.2 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Offered
11.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Laboratory Corporation of America Holdings Main Business Overview
11.7.5 Laboratory Corporation of America Holdings Latest Developments
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Information
11.8.2 Myriad Genetics, Inc. Pharmacogenomics (PGx) Product Offered
11.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Myriad Genetics, Inc. Main Business Overview
11.8.5 Myriad Genetics, Inc. Latest Developments
11.9 Pathway Genomics
11.9.1 Pathway Genomics Company Information
11.9.2 Pathway Genomics Pharmacogenomics (PGx) Product Offered
11.9.3 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pathway Genomics Main Business Overview
11.9.5 Pathway Genomics Latest Developments
11.10 Pfizer, Inc
11.10.1 Pfizer, Inc Company Information
11.10.2 Pfizer, Inc Pharmacogenomics (PGx) Product Offered
11.10.3 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pfizer, Inc Main Business Overview
11.10.5 Pfizer, Inc Latest Developments
11.11 Qiagen, Inc.
11.11.1 Qiagen, Inc. Company Information
11.11.2 Qiagen, Inc. Pharmacogenomics (PGx) Product Offered
11.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Qiagen, Inc. Main Business Overview
11.11.5 Qiagen, Inc. Latest Developments
11.12 Rocheg
11.12.1 Rocheg Company Information
11.12.2 Rocheg Pharmacogenomics (PGx) Product Offered
11.12.3 Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Rocheg Main Business Overview
11.12.5 Rocheg Latest Developments
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Information
11.13.2 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Offered
11.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.13.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Information
11.14.2 Thermo Fisher Scientific Pharmacogenomics (PGx) Product Offered
11.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Thermo Fisher Scientific Main Business Overview
11.14.5 Thermo Fisher Scientific Latest Developments
11.15 Transgenomic, Inc.
11.15.1 Transgenomic, Inc. Company Information
11.15.2 Transgenomic, Inc. Pharmacogenomics (PGx) Product Offered
11.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Transgenomic, Inc. Main Business Overview
11.15.5 Transgenomic, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmacogenomics (PGx) Market Size 2019-2030
2.1.2 Pharmacogenomics (PGx) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmacogenomics (PGx) Segment by Type
2.2.1 Polymerase Chain Reaction (PCR)
2.2.2 Microarray
2.2.3 Sequencing
2.2.4 Other
2.3 Pharmacogenomics (PGx) Market Size by Type
2.3.1 Pharmacogenomics (PGx) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
2.4 Pharmacogenomics (PGx) Segment by Application
2.4.1 Cardiovascular Diseases (CVD)
2.4.2 Central Nervous System (CNS)
2.4.3 Cancer/Oncology
2.4.4 Infectious Diseases
2.4.5 Other
2.5 Pharmacogenomics (PGx) Market Size by Application
2.5.1 Pharmacogenomics (PGx) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
3 PHARMACOGENOMICS (PGX) MARKET SIZE BY PLAYER
3.1 Pharmacogenomics (PGx) Market Size Market Share by Players
3.1.1 Global Pharmacogenomics (PGx) Revenue by Players (2019-2024)
3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacogenomics (PGx) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACOGENOMICS (PGX) BY REGIONS
4.1 Pharmacogenomics (PGx) Market Size by Regions (2019-2024)
4.2 Americas Pharmacogenomics (PGx) Market Size Growth (2019-2024)
4.3 APAC Pharmacogenomics (PGx) Market Size Growth (2019-2024)
4.4 Europe Pharmacogenomics (PGx) Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmacogenomics (PGx) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmacogenomics (PGx) Market Size by Country (2019-2024)
5.2 Americas Pharmacogenomics (PGx) Market Size by Type (2019-2024)
5.3 Americas Pharmacogenomics (PGx) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacogenomics (PGx) Market Size by Region (2019-2024)
6.2 APAC Pharmacogenomics (PGx) Market Size by Type (2019-2024)
6.3 APAC Pharmacogenomics (PGx) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmacogenomics (PGx) by Country (2019-2024)
7.2 Europe Pharmacogenomics (PGx) Market Size by Type (2019-2024)
7.3 Europe Pharmacogenomics (PGx) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmacogenomics (PGx) by Region (2019-2024)
8.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACOGENOMICS (PGX) MARKET FORECAST
10.1 Global Pharmacogenomics (PGx) Forecast by Regions (2025-2030)
10.1.1 Global Pharmacogenomics (PGx) Forecast by Regions (2025-2030)
10.1.2 Americas Pharmacogenomics (PGx) Forecast
10.1.3 APAC Pharmacogenomics (PGx) Forecast
10.1.4 Europe Pharmacogenomics (PGx) Forecast
10.1.5 Middle East & Africa Pharmacogenomics (PGx) Forecast
10.2 Americas Pharmacogenomics (PGx) Forecast by Country (2025-2030)
10.2.1 United States Pharmacogenomics (PGx) Market Forecast
10.2.2 Canada Pharmacogenomics (PGx) Market Forecast
10.2.3 Mexico Pharmacogenomics (PGx) Market Forecast
10.2.4 Brazil Pharmacogenomics (PGx) Market Forecast
10.3 APAC Pharmacogenomics (PGx) Forecast by Region (2025-2030)
10.3.1 China Pharmacogenomics (PGx) Market Forecast
10.3.2 Japan Pharmacogenomics (PGx) Market Forecast
10.3.3 Korea Pharmacogenomics (PGx) Market Forecast
10.3.4 Southeast Asia Pharmacogenomics (PGx) Market Forecast
10.3.5 India Pharmacogenomics (PGx) Market Forecast
10.3.6 Australia Pharmacogenomics (PGx) Market Forecast
10.4 Europe Pharmacogenomics (PGx) Forecast by Country (2025-2030)
10.4.1 Germany Pharmacogenomics (PGx) Market Forecast
10.4.2 France Pharmacogenomics (PGx) Market Forecast
10.4.3 UK Pharmacogenomics (PGx) Market Forecast
10.4.4 Italy Pharmacogenomics (PGx) Market Forecast
10.4.5 Russia Pharmacogenomics (PGx) Market Forecast
10.5 Middle East & Africa Pharmacogenomics (PGx) Forecast by Region (2025-2030)
10.5.1 Egypt Pharmacogenomics (PGx) Market Forecast
10.5.2 South Africa Pharmacogenomics (PGx) Market Forecast
10.5.3 Israel Pharmacogenomics (PGx) Market Forecast
10.5.4 Turkey Pharmacogenomics (PGx) Market Forecast
10.5.5 GCC Countries Pharmacogenomics (PGx) Market Forecast
10.6 Global Pharmacogenomics (PGx) Forecast by Type (2025-2030)
10.7 Global Pharmacogenomics (PGx) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Pharmacogenomics (PGx) Product Offered
11.1.3 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Affymetrix, Inc.
11.2.1 Affymetrix, Inc. Company Information
11.2.2 Affymetrix, Inc. Pharmacogenomics (PGx) Product Offered
11.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Affymetrix, Inc. Main Business Overview
11.2.5 Affymetrix, Inc. Latest Developments
11.3 Assurex Health, Inc
11.3.1 Assurex Health, Inc Company Information
11.3.2 Assurex Health, Inc Pharmacogenomics (PGx) Product Offered
11.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Assurex Health, Inc Main Business Overview
11.3.5 Assurex Health, Inc Latest Developments
11.4 Astrazeneca
11.4.1 Astrazeneca Company Information
11.4.2 Astrazeneca Pharmacogenomics (PGx) Product Offered
11.4.3 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Astrazeneca Main Business Overview
11.4.5 Astrazeneca Latest Developments
11.5 GeneDX
11.5.1 GeneDX Company Information
11.5.2 GeneDX Pharmacogenomics (PGx) Product Offered
11.5.3 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GeneDX Main Business Overview
11.5.5 GeneDX Latest Developments
11.6 Illumina, Inc.
11.6.1 Illumina, Inc. Company Information
11.6.2 Illumina, Inc. Pharmacogenomics (PGx) Product Offered
11.6.3 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Illumina, Inc. Main Business Overview
11.6.5 Illumina, Inc. Latest Developments
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Information
11.7.2 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Offered
11.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Laboratory Corporation of America Holdings Main Business Overview
11.7.5 Laboratory Corporation of America Holdings Latest Developments
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Information
11.8.2 Myriad Genetics, Inc. Pharmacogenomics (PGx) Product Offered
11.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Myriad Genetics, Inc. Main Business Overview
11.8.5 Myriad Genetics, Inc. Latest Developments
11.9 Pathway Genomics
11.9.1 Pathway Genomics Company Information
11.9.2 Pathway Genomics Pharmacogenomics (PGx) Product Offered
11.9.3 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pathway Genomics Main Business Overview
11.9.5 Pathway Genomics Latest Developments
11.10 Pfizer, Inc
11.10.1 Pfizer, Inc Company Information
11.10.2 Pfizer, Inc Pharmacogenomics (PGx) Product Offered
11.10.3 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pfizer, Inc Main Business Overview
11.10.5 Pfizer, Inc Latest Developments
11.11 Qiagen, Inc.
11.11.1 Qiagen, Inc. Company Information
11.11.2 Qiagen, Inc. Pharmacogenomics (PGx) Product Offered
11.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Qiagen, Inc. Main Business Overview
11.11.5 Qiagen, Inc. Latest Developments
11.12 Rocheg
11.12.1 Rocheg Company Information
11.12.2 Rocheg Pharmacogenomics (PGx) Product Offered
11.12.3 Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Rocheg Main Business Overview
11.12.5 Rocheg Latest Developments
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Information
11.13.2 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Offered
11.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.13.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Information
11.14.2 Thermo Fisher Scientific Pharmacogenomics (PGx) Product Offered
11.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Thermo Fisher Scientific Main Business Overview
11.14.5 Thermo Fisher Scientific Latest Developments
11.15 Transgenomic, Inc.
11.15.1 Transgenomic, Inc. Company Information
11.15.2 Transgenomic, Inc. Pharmacogenomics (PGx) Product Offered
11.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Transgenomic, Inc. Main Business Overview
11.15.5 Transgenomic, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmacogenomics (PGx) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polymerase Chain Reaction (PCR)
Table 3. Major Players of Microarray
Table 4. Major Players of Sequencing
Table 5. Major Players of Other
Table 6. Pharmacogenomics (PGx) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 9. Pharmacogenomics (PGx) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 12. Global Pharmacogenomics (PGx) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Pharmacogenomics (PGx) Revenue Market Share by Player (2019-2024)
Table 14. Pharmacogenomics (PGx) Key Players Head office and Products Offered
Table 15. Pharmacogenomics (PGx) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmacogenomics (PGx) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Pharmacogenomics (PGx) Market Size Market Share by Regions (2019-2024)
Table 20. Global Pharmacogenomics (PGx) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Pharmacogenomics (PGx) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Pharmacogenomics (PGx) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Pharmacogenomics (PGx) Market Size Market Share by Country (2019-2024)
Table 24. Americas Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 26. Americas Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 28. APAC Pharmacogenomics (PGx) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Pharmacogenomics (PGx) Market Size Market Share by Region (2019-2024)
Table 30. APAC Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 32. APAC Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 34. Europe Pharmacogenomics (PGx) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Pharmacogenomics (PGx) Market Size Market Share by Country (2019-2024)
Table 36. Europe Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 38. Europe Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Pharmacogenomics (PGx) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Pharmacogenomics (PGx)
Table 47. Key Market Challenges & Risks of Pharmacogenomics (PGx)
Table 48. Key Industry Trends of Pharmacogenomics (PGx)
Table 49. Global Pharmacogenomics (PGx) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Pharmacogenomics (PGx) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Pharmacogenomics (PGx) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Pharmacogenomics (PGx) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 54. Abbott Laboratories Pharmacogenomics (PGx) Product Offered
Table 55. Abbott Laboratories Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Affymetrix, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 59. Affymetrix, Inc. Pharmacogenomics (PGx) Product Offered
Table 60. Affymetrix, Inc. Main Business
Table 61. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Affymetrix, Inc. Latest Developments
Table 63. Assurex Health, Inc Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 64. Assurex Health, Inc Pharmacogenomics (PGx) Product Offered
Table 65. Assurex Health, Inc Main Business
Table 66. Assurex Health, Inc Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Assurex Health, Inc Latest Developments
Table 68. Astrazeneca Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 69. Astrazeneca Pharmacogenomics (PGx) Product Offered
Table 70. Astrazeneca Main Business
Table 71. Astrazeneca Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Astrazeneca Latest Developments
Table 73. GeneDX Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 74. GeneDX Pharmacogenomics (PGx) Product Offered
Table 75. GeneDX Main Business
Table 76. GeneDX Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GeneDX Latest Developments
Table 78. Illumina, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 79. Illumina, Inc. Pharmacogenomics (PGx) Product Offered
Table 80. Illumina, Inc. Main Business
Table 81. Illumina, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Illumina, Inc. Latest Developments
Table 83. Laboratory Corporation of America Holdings Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 84. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Offered
Table 85. Laboratory Corporation of America Holdings Main Business
Table 86. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Laboratory Corporation of America Holdings Latest Developments
Table 88. Myriad Genetics, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 89. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product Offered
Table 90. Myriad Genetics, Inc. Main Business
Table 91. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Myriad Genetics, Inc. Latest Developments
Table 93. Pathway Genomics Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 94. Pathway Genomics Pharmacogenomics (PGx) Product Offered
Table 95. Pathway Genomics Main Business
Table 96. Pathway Genomics Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Pathway Genomics Latest Developments
Table 98. Pfizer, Inc Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 99. Pfizer, Inc Pharmacogenomics (PGx) Product Offered
Table 100. Pfizer, Inc Main Business
Table 101. Pfizer, Inc Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Pfizer, Inc Latest Developments
Table 103. Qiagen, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 104. Qiagen, Inc. Pharmacogenomics (PGx) Product Offered
Table 105. Qiagen, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Qiagen, Inc. Main Business
Table 107. Qiagen, Inc. Latest Developments
Table 108. Rocheg Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 109. Rocheg Pharmacogenomics (PGx) Product Offered
Table 110. Rocheg Main Business
Table 111. Rocheg Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Rocheg Latest Developments
Table 113. Teva Pharmaceutical Industries Ltd. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 114. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Offered
Table 115. Teva Pharmaceutical Industries Ltd. Main Business
Table 116. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 118. Thermo Fisher Scientific Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 119. Thermo Fisher Scientific Pharmacogenomics (PGx) Product Offered
Table 120. Thermo Fisher Scientific Main Business
Table 121. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Thermo Fisher Scientific Latest Developments
Table 123. Transgenomic, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 124. Transgenomic, Inc. Pharmacogenomics (PGx) Product Offered
Table 125. Transgenomic, Inc. Main Business
Table 126. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Transgenomic, Inc. Latest Developments
Table 1. Pharmacogenomics (PGx) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polymerase Chain Reaction (PCR)
Table 3. Major Players of Microarray
Table 4. Major Players of Sequencing
Table 5. Major Players of Other
Table 6. Pharmacogenomics (PGx) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 9. Pharmacogenomics (PGx) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 12. Global Pharmacogenomics (PGx) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Pharmacogenomics (PGx) Revenue Market Share by Player (2019-2024)
Table 14. Pharmacogenomics (PGx) Key Players Head office and Products Offered
Table 15. Pharmacogenomics (PGx) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmacogenomics (PGx) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Pharmacogenomics (PGx) Market Size Market Share by Regions (2019-2024)
Table 20. Global Pharmacogenomics (PGx) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Pharmacogenomics (PGx) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Pharmacogenomics (PGx) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Pharmacogenomics (PGx) Market Size Market Share by Country (2019-2024)
Table 24. Americas Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 26. Americas Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 28. APAC Pharmacogenomics (PGx) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Pharmacogenomics (PGx) Market Size Market Share by Region (2019-2024)
Table 30. APAC Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 32. APAC Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 34. Europe Pharmacogenomics (PGx) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Pharmacogenomics (PGx) Market Size Market Share by Country (2019-2024)
Table 36. Europe Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 38. Europe Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Pharmacogenomics (PGx) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Pharmacogenomics (PGx)
Table 47. Key Market Challenges & Risks of Pharmacogenomics (PGx)
Table 48. Key Industry Trends of Pharmacogenomics (PGx)
Table 49. Global Pharmacogenomics (PGx) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Pharmacogenomics (PGx) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Pharmacogenomics (PGx) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Pharmacogenomics (PGx) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 54. Abbott Laboratories Pharmacogenomics (PGx) Product Offered
Table 55. Abbott Laboratories Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Affymetrix, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 59. Affymetrix, Inc. Pharmacogenomics (PGx) Product Offered
Table 60. Affymetrix, Inc. Main Business
Table 61. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Affymetrix, Inc. Latest Developments
Table 63. Assurex Health, Inc Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 64. Assurex Health, Inc Pharmacogenomics (PGx) Product Offered
Table 65. Assurex Health, Inc Main Business
Table 66. Assurex Health, Inc Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Assurex Health, Inc Latest Developments
Table 68. Astrazeneca Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 69. Astrazeneca Pharmacogenomics (PGx) Product Offered
Table 70. Astrazeneca Main Business
Table 71. Astrazeneca Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Astrazeneca Latest Developments
Table 73. GeneDX Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 74. GeneDX Pharmacogenomics (PGx) Product Offered
Table 75. GeneDX Main Business
Table 76. GeneDX Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GeneDX Latest Developments
Table 78. Illumina, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 79. Illumina, Inc. Pharmacogenomics (PGx) Product Offered
Table 80. Illumina, Inc. Main Business
Table 81. Illumina, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Illumina, Inc. Latest Developments
Table 83. Laboratory Corporation of America Holdings Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 84. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Offered
Table 85. Laboratory Corporation of America Holdings Main Business
Table 86. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Laboratory Corporation of America Holdings Latest Developments
Table 88. Myriad Genetics, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 89. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product Offered
Table 90. Myriad Genetics, Inc. Main Business
Table 91. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Myriad Genetics, Inc. Latest Developments
Table 93. Pathway Genomics Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 94. Pathway Genomics Pharmacogenomics (PGx) Product Offered
Table 95. Pathway Genomics Main Business
Table 96. Pathway Genomics Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Pathway Genomics Latest Developments
Table 98. Pfizer, Inc Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 99. Pfizer, Inc Pharmacogenomics (PGx) Product Offered
Table 100. Pfizer, Inc Main Business
Table 101. Pfizer, Inc Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Pfizer, Inc Latest Developments
Table 103. Qiagen, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 104. Qiagen, Inc. Pharmacogenomics (PGx) Product Offered
Table 105. Qiagen, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Qiagen, Inc. Main Business
Table 107. Qiagen, Inc. Latest Developments
Table 108. Rocheg Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 109. Rocheg Pharmacogenomics (PGx) Product Offered
Table 110. Rocheg Main Business
Table 111. Rocheg Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Rocheg Latest Developments
Table 113. Teva Pharmaceutical Industries Ltd. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 114. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Offered
Table 115. Teva Pharmaceutical Industries Ltd. Main Business
Table 116. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 118. Thermo Fisher Scientific Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 119. Thermo Fisher Scientific Pharmacogenomics (PGx) Product Offered
Table 120. Thermo Fisher Scientific Main Business
Table 121. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Thermo Fisher Scientific Latest Developments
Table 123. Transgenomic, Inc. Details, Company Type, Pharmacogenomics (PGx) Area Served and Its Competitors
Table 124. Transgenomic, Inc. Pharmacogenomics (PGx) Product Offered
Table 125. Transgenomic, Inc. Main Business
Table 126. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Transgenomic, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Pharmacogenomics (PGx) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacogenomics (PGx) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmacogenomics (PGx) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmacogenomics (PGx) Sales Market Share by Country/Region (2023)
Figure 8. Pharmacogenomics (PGx) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmacogenomics (PGx) Market Size Market Share by Type in 2023
Figure 10. Pharmacogenomics (PGx) in Cardiovascular Diseases (CVD)
Figure 11. Global Pharmacogenomics (PGx) Market: Cardiovascular Diseases (CVD) (2019-2024) & ($ Millions)
Figure 12. Pharmacogenomics (PGx) in Central Nervous System (CNS)
Figure 13. Global Pharmacogenomics (PGx) Market: Central Nervous System (CNS) (2019-2024) & ($ Millions)
Figure 14. Pharmacogenomics (PGx) in Cancer/Oncology
Figure 15. Global Pharmacogenomics (PGx) Market: Cancer/Oncology (2019-2024) & ($ Millions)
Figure 16. Pharmacogenomics (PGx) in Infectious Diseases
Figure 17. Global Pharmacogenomics (PGx) Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 18. Pharmacogenomics (PGx) in Other
Figure 19. Global Pharmacogenomics (PGx) Market: Other (2019-2024) & ($ Millions)
Figure 20. Global Pharmacogenomics (PGx) Market Size Market Share by Application in 2023
Figure 21. Global Pharmacogenomics (PGx) Revenue Market Share by Player in 2023
Figure 22. Global Pharmacogenomics (PGx) Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Pharmacogenomics (PGx) Market Size 2019-2024 ($ Millions)
Figure 24. APAC Pharmacogenomics (PGx) Market Size 2019-2024 ($ Millions)
Figure 25. Europe Pharmacogenomics (PGx) Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Pharmacogenomics (PGx) Market Size 2019-2024 ($ Millions)
Figure 27. Americas Pharmacogenomics (PGx) Value Market Share by Country in 2023
Figure 28. United States Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Pharmacogenomics (PGx) Market Size Market Share by Region in 2023
Figure 33. APAC Pharmacogenomics (PGx) Market Size Market Share by Type in 2023
Figure 34. APAC Pharmacogenomics (PGx) Market Size Market Share by Application in 2023
Figure 35. China Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Pharmacogenomics (PGx) Market Size Market Share by Country in 2023
Figure 42. Europe Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Figure 43. Europe Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Figure 44. Germany Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 58. APAC Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 59. Europe Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 61. United States Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 62. Canada Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 65. China Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 66. Japan Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 67. Korea Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 69. India Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 70. Australia Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 71. Germany Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 72. France Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 73. UK Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 74. Italy Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 75. Russia Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 76. Spain Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 79. Israel Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 82. Global Pharmacogenomics (PGx) Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Pharmacogenomics (PGx) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Pharmacogenomics (PGx) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacogenomics (PGx) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmacogenomics (PGx) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmacogenomics (PGx) Sales Market Share by Country/Region (2023)
Figure 8. Pharmacogenomics (PGx) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmacogenomics (PGx) Market Size Market Share by Type in 2023
Figure 10. Pharmacogenomics (PGx) in Cardiovascular Diseases (CVD)
Figure 11. Global Pharmacogenomics (PGx) Market: Cardiovascular Diseases (CVD) (2019-2024) & ($ Millions)
Figure 12. Pharmacogenomics (PGx) in Central Nervous System (CNS)
Figure 13. Global Pharmacogenomics (PGx) Market: Central Nervous System (CNS) (2019-2024) & ($ Millions)
Figure 14. Pharmacogenomics (PGx) in Cancer/Oncology
Figure 15. Global Pharmacogenomics (PGx) Market: Cancer/Oncology (2019-2024) & ($ Millions)
Figure 16. Pharmacogenomics (PGx) in Infectious Diseases
Figure 17. Global Pharmacogenomics (PGx) Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 18. Pharmacogenomics (PGx) in Other
Figure 19. Global Pharmacogenomics (PGx) Market: Other (2019-2024) & ($ Millions)
Figure 20. Global Pharmacogenomics (PGx) Market Size Market Share by Application in 2023
Figure 21. Global Pharmacogenomics (PGx) Revenue Market Share by Player in 2023
Figure 22. Global Pharmacogenomics (PGx) Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Pharmacogenomics (PGx) Market Size 2019-2024 ($ Millions)
Figure 24. APAC Pharmacogenomics (PGx) Market Size 2019-2024 ($ Millions)
Figure 25. Europe Pharmacogenomics (PGx) Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Pharmacogenomics (PGx) Market Size 2019-2024 ($ Millions)
Figure 27. Americas Pharmacogenomics (PGx) Value Market Share by Country in 2023
Figure 28. United States Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Pharmacogenomics (PGx) Market Size Market Share by Region in 2023
Figure 33. APAC Pharmacogenomics (PGx) Market Size Market Share by Type in 2023
Figure 34. APAC Pharmacogenomics (PGx) Market Size Market Share by Application in 2023
Figure 35. China Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Pharmacogenomics (PGx) Market Size Market Share by Country in 2023
Figure 42. Europe Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Figure 43. Europe Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Figure 44. Germany Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Pharmacogenomics (PGx) Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Pharmacogenomics (PGx) Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 58. APAC Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 59. Europe Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 61. United States Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 62. Canada Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 65. China Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 66. Japan Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 67. Korea Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 69. India Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 70. Australia Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 71. Germany Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 72. France Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 73. UK Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 74. Italy Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 75. Russia Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 76. Spain Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 79. Israel Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Pharmacogenomics (PGx) Market Size 2025-2030 ($ Millions)
Figure 82. Global Pharmacogenomics (PGx) Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Pharmacogenomics (PGx) Market Size Market Share Forecast by Application (2025-2030)
